TY - JOUR
T1 - Long-term outcome of steroid-resistant nephrotic syndrome in children
AU - Trautmann, Agnes
AU - Schnaidt, Sven
AU - Lipska-Ziȩtkiewicz, Beata S.
AU - Bodria, Monica
AU - Ozaltin, Fatih
AU - Emma, Francesco
AU - Anarat, Ali
AU - Melk, Anette
AU - Azocar, Marta
AU - Oh, Jun
AU - Saeed, Bassam
AU - Gheisari, Alaleh
AU - Caliskan, Salim
AU - Gellermann, Jutta
AU - Higuita, Lina Maria Serna
AU - Jankauskiene, Augustina
AU - Drozdz, Dorota
AU - Mir, Sevgi
AU - Balat, Ayse
AU - Szczepanska, Maria
AU - Paripovic, Dusan
AU - Zurowska, Alexandra
AU - Bogdanovic, Radovan
AU - Yilmaz, Alev
AU - Ranchin, Bruno
AU - Baskin, Esra
AU - Erdogan, Ozlem
AU - Remuzzi, Giuseppe
AU - Firszt-Adamczyk, Agnieszka
AU - Kuzma-Mroczkowska, Elzbieta
AU - Litwin, Mieczyslaw
AU - Murer, Luisa
AU - Tkaczyk, Marcin
AU - Jardim, Helena
AU - Wasilewska, Anna
AU - Printza, Nikoleta
AU - Fidan, Kibriya
AU - Simkova, Eva
AU - Borzecka, Halina
AU - Staude, Hagen
AU - Hees, Katharina
AU - Schaefer, Franz
PY - 2017/10/1
Y1 - 2017/10/1
N2 - Weinvestigated the value of genetic, histopathologic, and early treatment response information inprognosing longterm renal outcome in children with primary steroid-resistant nephrotic syndrome. From the PodoNet Registry, we obtained longitudinal clinical information for 1354 patients (disease onset at>3months and<20 years of age): 612 haddocumentedresponsiveness tointensifiedimmunosuppression (IIS),1155hadkidneybiopsy results, and212had an established genetic diagnosis. We assessed risk factors for ESRD using multivariate Cox regression models. Complete and partial remission of proteinuria within 12 months of disease onset occurred in 24.5% and 16.5% of children, respectively, with the highest remission rates achievedwith calcineurin inhibitor-based protocols. Ten-year ESRD-free survival rates were 43%, 94%, and 72% in children with IIS resistance, complete remission, and partial remission, respectively; 27% in children with a genetic diagnosis; and 79% and 52% in children with histopathologic findings of minimal change glomerulopathy and FSGS, respectively. Five-year ESRD-free survival rate was 21% for diffuse mesangial sclerosis. IIS responsiveness, presence of a genetic diagnosis, and FSGS or diffuse mesangial sclerosis on initial biopsy as well as age, serum albumin concentration, and CKD stage at onset affected ESRD risk. Our findings suggest that responsiveness to initial IIS and detection of a hereditary podocytopathy are prognostic indicators of favorable and poor long-term outcome, respectively, in children with steroid-resistant nephrotic syndrome. Childrenwithmultidrug-resistant sporadic disease showbetter renal survival than thosewith geneticdisease. Furthermore, histopathologic findings may retain prognostic relevance when a genetic diagnosis is established.
AB - Weinvestigated the value of genetic, histopathologic, and early treatment response information inprognosing longterm renal outcome in children with primary steroid-resistant nephrotic syndrome. From the PodoNet Registry, we obtained longitudinal clinical information for 1354 patients (disease onset at>3months and<20 years of age): 612 haddocumentedresponsiveness tointensifiedimmunosuppression (IIS),1155hadkidneybiopsy results, and212had an established genetic diagnosis. We assessed risk factors for ESRD using multivariate Cox regression models. Complete and partial remission of proteinuria within 12 months of disease onset occurred in 24.5% and 16.5% of children, respectively, with the highest remission rates achievedwith calcineurin inhibitor-based protocols. Ten-year ESRD-free survival rates were 43%, 94%, and 72% in children with IIS resistance, complete remission, and partial remission, respectively; 27% in children with a genetic diagnosis; and 79% and 52% in children with histopathologic findings of minimal change glomerulopathy and FSGS, respectively. Five-year ESRD-free survival rate was 21% for diffuse mesangial sclerosis. IIS responsiveness, presence of a genetic diagnosis, and FSGS or diffuse mesangial sclerosis on initial biopsy as well as age, serum albumin concentration, and CKD stage at onset affected ESRD risk. Our findings suggest that responsiveness to initial IIS and detection of a hereditary podocytopathy are prognostic indicators of favorable and poor long-term outcome, respectively, in children with steroid-resistant nephrotic syndrome. Childrenwithmultidrug-resistant sporadic disease showbetter renal survival than thosewith geneticdisease. Furthermore, histopathologic findings may retain prognostic relevance when a genetic diagnosis is established.
UR - http://www.scopus.com/inward/record.url?scp=85030457670&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030457670&partnerID=8YFLogxK
U2 - 10.1681/ASN.2016101121
DO - 10.1681/ASN.2016101121
M3 - Article
C2 - 28566477
AN - SCOPUS:85030457670
VL - 28
SP - 3055
EP - 3065
JO - Journal of the American Society of Nephrology : JASN
JF - Journal of the American Society of Nephrology : JASN
SN - 1046-6673
IS - 10
ER -